rs778692211
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_015450.3(POT1):c.238C>T(p.Arg80Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000106 in 1,606,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015450.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POT1 | NM_015450.3 | c.238C>T | p.Arg80Cys | missense_variant | Exon 7 of 19 | ENST00000357628.8 | NP_056265.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152048Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246590Hom.: 0 AF XY: 0.0000300 AC XY: 4AN XY: 133450
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1454242Hom.: 0 Cov.: 29 AF XY: 0.00000829 AC XY: 6AN XY: 723438
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152048Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74262
ClinVar
Submissions by phenotype
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with multiple primary melanoma (Muller 2018); This variant is associated with the following publications: (PMID: 28393830, 29523635) -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R80C variant (also known as c.238C>T), located in coding exon 3 of the POT1 gene, results from a C to T substitution at nucleotide position 238. The arginine at codon 80 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration was detected in an Austrian individual with multiple primary melanomas but was not present in the control cohort (Müller C et al. G3 (Bethesda). 2018 05;8:1475-1480). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. -
Tumor predisposition syndrome 3 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 80 of the POT1 protein (p.Arg80Cys). This variant is present in population databases (rs778692211, gnomAD 0.009%). This missense change has been observed in individual(s) with melanoma (PMID: 29523635). ClinVar contains an entry for this variant (Variation ID: 541863). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt POT1 protein function with a negative predictive value of 80%. RNA analysis performed to evaluate the impact of this missense change on mRNA splicing indicates it does not significantly alter splicing (internal data). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at